FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to pharmaceutics and medicine and concerns a composition for oral administration containing protein having molecular weight up to 100000 Da, an absorption intensifier specified in a group of: SNAC, SNAD, or salts thereof, a protease inhibitor; there are also declared methods of treating diabetes mellitus involving the administration of the above composition, and a method for oral administration of protein with enzymatic activity.
EFFECT: group of inventions provides substantially increased protein bioavailability and ease of use.
16 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS | 2013 |
|
RU2646828C2 |
| METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS | 2009 |
|
RU2504373C2 |
| COMPOSITIONS AND METHODS FOR ORAL ADMINISTRATION OF EXENATIDE | 2009 |
|
RU2566063C2 |
| MIMETIC CALCITONIN FOR TREATING DISEASES AND DISORDERS | 2014 |
|
RU2689551C1 |
| APPLICATION OF CALCITONIN FOR TREATING RHEUMATOID ARTHRITIS | 2006 |
|
RU2453330C2 |
| CALCITONIN USED AT OSTEOARTHRITIS | 2004 |
|
RU2368390C2 |
| METHODS FOR PREPARING ACYCLOVIR FORMULATION | 2005 |
|
RU2406504C2 |
| SOLID COMPOSITIONS FOR ORAL ADMINISTRATION | 2018 |
|
RU2777206C2 |
| TREATING DIABETES AND METABOLIC SYNDROME | 2010 |
|
RU2537181C2 |
| COMPOSITIONS FOR DRUG INTRODUCTION | 2009 |
|
RU2554814C2 |
